Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Catalent Inc (NY: CTLT )

115.50 USD +0.26 (+0.23%)
Official Closing Price Updated: 7:47 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Catalent Inc

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Teladoc, Intuitive Surgical, TMO Stock Near Buy Points As Covid Testing Ramps Up, Vaccines Lift Outlook
Thermo Fisher, Catalent, Teladoc Health, One Medical and ISRG stock are rallying on Covid testing and coronavirus vaccine rollouts and post-pandemic hopes. 
From Investor's Business Daily
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SUPN CTLT Offerings
From Benzinga
Catalent, Inc. to Present at the 39th Annual J.P. Morgan Healthcare Conference
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
From Business Wire News Releases
These are the best-performing Nasdaq and S&P 500 stocks of 2020
COVID-19 has rewarded companies at the cutting edge of mobility and remote working. 
Tags PFE OKTA AMD
From MarketWatch
First Week of February 2021 Options Trading For Catalent (CTLT)
Investors in Catalent Inc (CTLT) saw new options begin trading this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CTLT options... 
Tags Stocks
From Market News Video
Linde Achieves #32 Analyst Rank, Surpassing Catalent
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Linde plc (LIN) has taken over the #32 spot from Catalent Inc (CTLT), according to ETF... 
Tags ETFs
From ETF Channel
VMware Larger Than S&P 500 Component Catalent
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component VMware Inc (VMW) was identified as having a larger market cap than the smaller end of the S&P 500, for... 
Tags Stocks
From Market News Video
Catalent Joins Rank Of Stocks With 95-Plus Composite Rating
On Friday, Catalent got an upgrade for its IBD SmartSelect Composite Rating from 94 to 96. 
From Investor's Business Daily
KeyBanc Upgrades Catalent On Industry Transformation
Catalent Inc (NYSE: CTLT) is a “key component” of the transformation of the health care industry from pharma to biopharma, ... 
Tags Upgrades Price Target CTLT
From Benzinga
A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Earnings, Economic Data
Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade after the Nasdaq tumbled around 2% in the ... 
Tags ORCL Benzinga COST
From Benzinga
S&P 500 Movers: CTLT, GPS
In early trading on Monday, shares of The Gap topped the list of the day's best performing components of the S&P 500 index, trading up 7.0%. Year to date, The Gap registers a 47.5% gain. 
Tags Stocks
From Market News Video
S&P 500 Inductees: Class of 2020
Historically over the past decade, new entrants to the large-cap benchmark have on average risen in the months leading up to inclusion. In the immediate days following inclusion 
Tags Stocks / Equities
From Blogs - TalkMarkets
Here’s how Tesla’s S&P 500 inclusion may play out
Tesla Inc. stock continues to surge on news of an S&P 500 inclusion, but the sheer size of the Silicon Valley electric-car maker adds complexity to the addition. 
Tags SPX TSLA MRO
From MarketWatch
Catalent, Inc. to Present at November 2020 Virtual Investor Conferences
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
From Business Wire News Releases
The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags News Benzinga CTIC
From Benzinga
Stocks That Hit 52-Week Highs On Monday
During Monday's morning session, 460 companies made new 52-week highs. Things to Consider: The company with the ... 
Tags CTRN MORN NEP
From Benzinga
Stocks That Hit 52-Week Highs On Friday
During the morning session on Friday, 177 stocks hit new 52-week highs. Interesting Points: Abbott Laboratories ... 
Tags STRO SSTK BST
From Benzinga
Catalent Could Be A Big COVID-19 Vaccine Play: The Thing Behind The Thing
Each week, Benzinga will examine a stock that might be considered a little under the radar. You may have never heard of the company ... 
Tags Trading Ideas General Operation Warp Speed
From Benzinga
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Penny Stocks EIDX Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 213 companies set new 52-week highs. Facts of Interest: Alphabet (NASDAQ: GOOG) ... 
Tags ACHC GNRC TT
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
This morning 118 companies reached new 52-week highs. Noteworthy Points: Alphabet (NASDAQ: GOOG) was the company with ... 
Tags HOV PKI IMVT
From Benzinga
Stock Upgrades: Catalent Shows Rising Relative Strength
Catalent shows rising price performance, earning an upgrade to its IBD Relative Strength Rating. 
From Investor's Business Daily
A Look Into Catalent's Price Over Earnings
In the current session,Catalent Inc. (NYSE: CTLT)is trading at $94.28, after a6.52%gain. Over the past ... 
Tags Intraday Update Market News CTLT
From Benzinga
The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ORPH GWPH OSUR
From Benzinga
Catalent, Inc. Reports First Quarter Fiscal 2021 Results
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
From Business Wire News Releases
Earnings Scheduled For November 3, 2020
Companies Reporting Before The Bell • Expeditors International (NASDAQ:EXPD) is likely to report quarterly earnings at ... 
Tags ITUB RNWK Market News
From Benzinga
Interesting CTLT Put And Call Options For October 2021
Investors in Catalent Inc (CTLT) saw new options begin trading today, for the October 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time... 
Tags Stocks
From Market News Video
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ... 
Tags EGRX News Benzinga
From Benzinga
Stocks To Watch With Next Quarterly Report On Tap: Catalent
Catalent (CTLT) is expected to report earnings on Nov. 3. Catalent now trading 4% below the 95.80 buy point from a first-stage cup without handle that it cleared earlier. Understand that buying a stock... 
From Investor's Business Daily
Catalent and BrainStorm Cell Therapeutics Announce Partnership for the Manufacture of Mesenchymal Stem Cell Platform Therapy NurOwn®
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.